Manulife (Manufacturers Life Insurance)
BMY.RT

Manulife (Manufacturers Life Insurance)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,751
Closed -$11K – 3213
2020
Q4 		$11K Hold
15,751
– – ﹤0.01% 2981
2020
Q3 		$35K Hold
15,751
– – ﹤0.01% 2896
2020
Q2 		$54K Sell
15,751
-1,959
-11% -$7.07K ﹤0.01% 2827
2020
Q1 		$67K Hold
17,710
– – ﹤0.01% 2677
2019
Q4 		$53K Buy
+17,710
New +$46.1K ﹤0.01% 2846

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BMY.RT Position: Q1 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 15,751 shares — an estimated $11K sold.

Manulife (Manufacturers Life Insurance) first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $67K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 15,751 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $11K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $67K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2021, filed 3 May 2021.